|
| |
| | | 52535 | | 25.08.1994 | | Novartis Pharma Schweiz AG | | 15.09.2004 | | | | | | | | | | | 01.12. | | | | 01.12. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Lioresal intrathecal 0,05 mg/1 mL | Ampullen | (Baclofen 50 µg/ml) | M03BX01 | CI | | 02 | Lioresal intrathecal 10 mg/5 mL | Ampullen | (Baclofen 10mg / 5ml) | M03BX01 | CI | | 03 | Lioresal intrathecal 10 mg/20 mL | Ampullen | (Baclofen 10mg / 20ml) | M03BX01 | CI |
|
|
|
